DoriNano Overview

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed
  • (In Progress)

  • Investors
  • 15

DoriNano General Information

Description

Developer of a biotechnology platform intended to advance precision drug delivery through deoxyribonucleic acid origami nanotechnology. The company offers customizable three-dimensional nanoparticles for targeted therapeutic delivery, enabling pharmaceutical companies, biotechnology organizations, and healthcare researchers to develop targeted therapies with improved delivery precision.

Contact Information

Website
www.dorinano.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 700 Main Street
  • Cambridge, MA 02139
  • United States
+1 (781)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, Life Sciences
Corporate Office
  • 700 Main Street
  • Cambridge, MA 02139
  • United States
+1 (781)

DoriNano Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DoriNano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Seed Round 25-May-2026 In Progress Startup
16. Accelerator/Incubator 26-May-2026 Completed Startup
15. Grant Completed Startup
14. Accelerator/Incubator Completed Startup
13. Accelerator/Incubator 23-Jan-2026 Completed Startup
12. Angel (individual) 01-Jan-2026 Completed Startup
11. Accelerator/Incubator 01-Jan-2026 Completed Startup
10. Accelerator/Incubator 06-Nov-2025 Completed Startup
9. Accelerator/Incubator 06-Nov-2025 $50K $250K Completed Startup
8. Accelerator/Incubator 01-May-2025 $200K Completed Startup
To view DoriNano’s complete valuation and funding history, request access »

DoriNano Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DoriNano Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioTools Innovator Accelerator/Incubator
MedTech Innovator Accelerator/Incubator
Cure Experience Services Accelerator/Incubator
LabCentral Accelerator/Incubator
University of Toronto University
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

DoriNano FAQs

  • Where is DoriNano headquartered?

    DoriNano is headquartered in Cambridge, MA.

  • What is the size of DoriNano?

    DoriNano has 3 total employees.

  • What industry is DoriNano in?

    DoriNano’s primary industry is Drug Delivery.

  • Is DoriNano a private or public company?

    DoriNano is a Private company.

  • What is DoriNano’s current revenue?

    The current revenue for DoriNano is .

  • How much funding has DoriNano raised over time?

    DoriNano has raised $780K.

  • Who are DoriNano’s investors?

    BioTools Innovator, MedTech Innovator, Cure Experience Services, LabCentral, and University of Toronto are 5 of 15 investors who have invested in DoriNano.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process